cohbar
announce
third
quarter
financial
results
provide
business
update
november
menlo
park
globe
newswire
cohbar
nasdaq
cwbr
clinical
stage
biotechnology
company
developing
mitochondria
based
therapeutics
treat
chronic
diseases
extend
healthy
lifespan
announced
today
company
release
third
quarter
financial
results
market
closes
monday
november
management
host
conference
call
slide
presentation
et
pt
day
provide
update
company
business
details
conference
call
slide
presentation
date
november
time
et
pt
conference
audio
canada
international
conference
id
slide
presentation
go
click
join
meeting
button
enter
meeting
number
password
cwbr
go
click
shareholder
presentation
top
homepage
individuals
participating
investor
call
slide
presentation
please
call
conference
audio
log
webex
approximately
minutes
prior
start
audio
replay
call
available
beginning
eastern
time
november
eastern
time
december
access
recording
please
dial
canada
internationally
reference
conference
id
audio
recording
along
slide
presentation
also
available
period
cohbar
cohbar
nasdaq
cwbr
clinical
stage
biotechnology
company
focused
research
development
mitochondria
based
therapeutics
emerging
class
drugs
treatment
chronic
diseases
mitochondria
based
therapeutics
originate
discovery
cohbar
founders
novel
group
naturally
occurring
peptide
sequences
within
mitochondrial
genome
shown
potential
regulate
key
processes
multiple
systems
organs
body
date
company
discovered
mitochondrial
derived
peptides
generated
analogs
cohbar
efforts
focus
development
peptides
therapeutics
offer
potential
address
broad
range
diseases
underlying
impact
mitochondrial
dysfunction
company
lead
compound
phase
stage
phase
clinical
trial
nash
obesity
addition
cohbar
four
preclinical
programs
analogs
fibrotic
diseases
analogs
associated
ards
analogs
cancer
orphan
diseases
analogs
cancer
immunotherapy
additional
company
information
please
visit
statements
news
release
contains
statements
historical
facts
within
meaning
private
securities
litigation
reform
act
statements
based
current
beliefs
expectations
assumptions
regarding
future
business
future
plans
strategies
projections
anticipated
events
future
conditions
cases
identify
statements
words
believe
may
estimate
continue
anticipate
intend
could
would
project
plan
expect
goal
seek
future
likely
negative
plural
words
similar
expressions
examples
statements
including
limited
anticipated
outcomes
research
clinical
trials
mitochondria
based
therapeutic
mbt
candidates
expectations
regarding
growth
mbts
significant
future
class
drug
products
statements
regarding
anticipated
therapeutic
properties
potential
mitochondrial
peptide
analogs
mbts
cautioned
statements
guarantees
future
performance
actual
results
developments
may
differ
materially
set
forth
statements
factors
could
cause
actual
results
differ
materially
statements
include
ability
successfully
advance
drug
discovery
development
programs
including
delay
termination
ongoing
clinical
trials
possible
inability
mitigate
prevalence
persistence
injection
site
reactions
receipt
unfavorable
feedback
regulators
regarding
safety
tolerability
possibility
developments
affecting
viability
clinical
candidate
commercial
potential
results
different
earlier
data
results
including
less
favorable
may
support
clinical
development
ability
raise
additional
capital
necessary
continue
operations
ability
recruit
retain
key
management
scientific
personnel
risk
intellectual
property
may
adequately
protected
ability
establish
maintain
partnerships
corporate
industry
partners
risks
related
impact
business
pandemic
similar
public
health
crises
including
limited
impact
ongoing
planned
clinical
trials
additional
assumptions
risks
uncertainties
described
detail
registration
statements
reports
filings
securities
exchange
commission
applicable
canadian
securities
regulators
available
website
cautioned
statements
guarantees
future
performance
actual
results
may
differ
materially
set
forth
statements
statements
information
contained
news
release
made
date
hereof
cohbar
undertake
obligation
update
publicly
revise
statements
information
whether
result
new
information
future
events
otherwise
unless
required
applicable
securities
laws
nothing
herein
shall
constitute
offer
sell
solicitation
offer
buy
securities
investor
media
contact
jordyn
tarazi
director
investor
relations
cohbar
joyce
allaire
lifesci
advisors
llc
jallaire
